Brain 17 Vienna
non-small cell lung cancer brain metastases RTOG 0320
1 – 3 brain metastases
randomise
whole brain radiotherapy & SRS
Temozolomide
Erlotinib
control
Temozolomide
Erlotinib
not biomarker enriched
Additional systemic therapy in NSCLC brain metastases
Sperduto et al 2013, Int J Radiat Oncol Biol Phys, 85(5): 1312-8
Made with FlippingBook - Online catalogs